Oconitrillo M, Wickramasinghe J, Omale S, Beitz D, Appuhamy R
For patient treatment, approved GLP-1 or GIP/GLP-1 medications remain the practical comparison point until regulators decide whether to approve cagrilintide-containing products
The jury's still out on that
A recent randomized clinical trial from Denmark evaluated weight loss maintenance after one of four 52-week regimens (placebo, once daily liraglutide 3.0 mg alone, supervised exercise alone, or liraglutide plus supervised exercise) in 109 adults with obesity without serious chronic illnesses, including diabetes
discontinuing use within the first 3 months
This advanced delivery system may enhance the effectiveness of glutathione supplements, allowing your body to utilize the antioxidant more efficiently